Form 4: Odysight.ai CBO Granted 15,000 Stock Options

Odysight.ai Inc.'s Chief Business Officer, Eilam Sagi, was granted 15,000 options to purchase common stock with an exercise price of $5.14.

Summary

• Eilam Sagi, Chief Business Officer of Odysight.ai Inc. (ODYS), was granted 15,000 options to purchase common stock.
• The options have an exercise price of $5.14 per share.
• The grant date for these options was February 19, 2026.
• The options expire on February 19, 2036.
• Vesting occurs in stages: one-third of the shares vest on November 15, 2026, with the remainder vesting in equal quarterly installments over the subsequent 24 months, fully vesting by November 15, 2028.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, indicating management retention and alignment of interests, though it's a routine compensation matter rather than a major strategic announcement.

Positives

• Grant of stock options to the Chief Business Officer aligns management incentives with shareholder interests.
• The options have a 10-year expiration period, providing a long-term incentive for the executive.

Negatives

• No immediate negative financial impact is apparent from a routine stock option grant.

Risks

• Potential dilution for existing shareholders if options are exercised in the future.
• The value of the options is dependent on the future stock price exceeding the exercise price of $5.14.

Future Outlook

The grant of stock options to a key executive suggests a long-term commitment to the company's future performance and growth, with the vesting schedule designed to retain the executive over several years.

Management Comments

• No direct management comments or quotes are provided in this Form 4 filing, which is typical for this document type.

Industry Context

StockSavvy.ai notes that granting stock options is a standard practice in the technology and growth sectors to attract, retain, and incentivize key talent. This aligns the executive's financial interests with the long-term success of Odysight.ai, a common strategy among companies like Palantir Technologies or C3.ai, which also utilize equity compensation to motivate leadership in developing advanced AI and vision solutions.

Comparison to Industry Standards

• The exercise price of $5.14 per share is set at the market price on the grant date, which is a common industry practice for incentive stock options.
• A 10-year expiration period is typical for executive stock options, providing ample time for the stock price to appreciate.
• The multi-year vesting schedule (over 2 years and 9 months from grant date to full vesting) is standard for executive retention, comparable to vesting schedules seen at companies like NVIDIA or Microsoft for their senior leadership.

Stakeholder Impact

• Shareholders: Potential for minor dilution if options are exercised, but also benefit from incentivized management.
• Employees: May signal confidence in the company's future, potentially boosting morale.

Next Steps

• Eilam Sagi will continue to hold the options, subject to the vesting schedule.
• The options will become exercisable in tranches starting November 15, 2026.

Key Dates

Recommendation

This Form 4 reports a routine executive compensation event (stock option grant) and does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It primarily indicates management retention and alignment of interests, which is generally positive but not a catalyst for a 'buy' or 'sell' decision on its own.

Keywords

Odysight.ai, ODYS, Stock Options, Executive Compensation, Form 4, Insider Transaction, Eilam Sagi, Chief Business Officer, Equity Grant